Study shows curcumin enhances antiretroviral delivery and reduces inflammation and oxidative stress in HIV, offering potential improvements in treating HIV-associated neurocognitive disorders.
Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) – Biotech Investments
Biophytis / Key word(s): Miscellaneous Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) 08-Apr-2024 / 23:00 CET/CEST Biophytis launches OBA phase